Analysis

The advertising technology sector is witnessing a potential paradigm shift as The Trade Desk, a prominent programmatic advertising specialist, unveils...

Marvell Technology finds itself at a critical juncture as corporate leadership and market analysts present dramatically different assessments of the...

The biotechnology sector has a new standout performer as Intellia Therapeutics demonstrates significant momentum across multiple fronts. Clinical trial progress,...

The insurance and consulting titan Marsh McLennan stands at a critical juncture this week, navigating a significant executive appointment while...

The cybersecurity firm Fortinet is navigating turbulent waters, with investor concerns extending far beyond recent share price weakness. A combination...

Medical technology giant Becton Dickinson enters October with notable momentum, propelled by multiple strategic developments that could signal a potential...

aTyr Pharma's stock continues its downward spiral as disappointing clinical trial results trigger a massive selloff. The biotechnology firm's shares...

The battle for cloud supremacy is increasingly being fought with artificial intelligence as the primary weapon. Workday has made a...

A significant shift is underway in the construction and design software sector, with Autodesk emerging as a potential primary beneficiary...

Biogen has achieved significant regulatory and clinical milestones for its Alzheimer's treatment Leqembi, positioning the biotechnology firm for potential growth...